Cite
Impact of pitavastatin on new-onset diabetes mellitus compared to atorvastatin and rosuvastatin: a distributed network analysis of 10 real-world databases.
MLA
Seo, Won-Woo, et al. “Impact of Pitavastatin on New-Onset Diabetes Mellitus Compared to Atorvastatin and Rosuvastatin: A Distributed Network Analysis of 10 Real-World Databases.” Cardiovascular Diabetology, vol. 21, no. 1, May 2022, pp. 1–14. EBSCOhost, https://doi.org/10.1186/s12933-022-01524-6.
APA
Seo, W.-W., Seo, S. I., Kim, Y., Yoo, J. J., Shin, W. G., Kim, J., You, S. C., Park, R. W., Park, Y. M., Kim, K.-J., Rhee, S. Y., Park, M., Jin, E.-S., & Kim, S. E. (2022). Impact of pitavastatin on new-onset diabetes mellitus compared to atorvastatin and rosuvastatin: a distributed network analysis of 10 real-world databases. Cardiovascular Diabetology, 21(1), 1–14. https://doi.org/10.1186/s12933-022-01524-6
Chicago
Seo, Won-Woo, Seung In Seo, Yerim Kim, Jong Jin Yoo, Woon Geon Shin, Jinseob Kim, Seng Chan You, et al. 2022. “Impact of Pitavastatin on New-Onset Diabetes Mellitus Compared to Atorvastatin and Rosuvastatin: A Distributed Network Analysis of 10 Real-World Databases.” Cardiovascular Diabetology 21 (1): 1–14. doi:10.1186/s12933-022-01524-6.